Systemic chemotherapy decreases brain glucose metabolism

OBJECTIVE: Cancer patients may experience neurologic adverse effects, such as alterations in neurocognitive function, as a consequence of chemotherapy. The mechanisms underlying such neurotoxic syndromes remain poorly understood. We here describe the temporal and regional effects of systemically adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Horky, Laura L, Gerbaudo, Victor H, Zaitsev, Alexander, Plesniak, Wen, Hainer, Jon, Govindarajulu, Usha, Kikinis, Ron, Dietrich, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241806/
https://www.ncbi.nlm.nih.gov/pubmed/25493270
http://dx.doi.org/10.1002/acn3.121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241806/
https://www.ncbi.nlm.nih.gov/pubmed/25493270
http://dx.doi.org/10.1002/acn3.121

Ejemplares similares